TiGenix (Spain)

TiGenix (Spain)

TiGenix is a European cell therapy company with a proprietary validated allogeneic expanded adipose-derived stem cell platform technology for the treatment of autoimmune and inflammatory diseases, and a commercialized product. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for TiGenix (Spain), Spain, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

73%


Total
Publications

171


Total Open
Publications

125


Total
Citations

4.7K


Open Access
Percentage

73%


Total
Publications

171


Total Open
Publications

125


Total
Citations

4.7K

Wikipedia

Website

download

Breakdown

24% 37% 9% 30%

Publisher Open

24%

Both

37%

Other Platform Open

9%

Closed

30%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

024681012141618Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

54%OA Journal

OA Journal 54%

52

Hybrid 19%

18

No Guarantees 27%

26

Other Platform Open

Domain 51%

39

Institution 47%

36

Other Internet 31%

24

Preprint 8%

6

Public 5%

4

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
36
DOI
Other Internet
23
Royal Netherlands Academy of Arts and Sciences
Institution
6
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
6
Europe PMC
Domain
6
Zenodo
Public
4
Universitat Autònoma de Barcelona
Institution
4
University of Malta
Institution
3
Universitat Politècnica de Catalunya
Institution
3
Consejo Superior de Investigaciones Científicas
Institution
3
1 / 4

Data updated 18 August 2025

Share

Share

Share